Gut microbiota and pattern recognition receptors in polycystic ovary syndrome
Journal of Reproductive Immunology · 2026-06 · 175 · 104882
DOI: 10.1016/j.jri.2026.104882 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Reproductive Immunology, 2026-06. Verfasst von Jintao Yuan und 5 weiteren Autor:innen. Beteiligte Einrichtung: The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Zhenjiang, Jiangsu 212300, PR China. Hauptthemen laut MEDLINE: Dysbiosis, Gastrointestinal Microbiome, Polycystic Ovary Syndrome, Receptors, Pattern Recognition. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 120 Literaturangaben. Gefördert von: Jiangsu Commission of Health.
Abstract (Originalsprache)
Polycystic ovary syndrome (PCOS) is increasingly recognized as a disorder of impaired immune-endocrine homeostasis. Emerging evidence indicates that intestinal dysbiosis and microbial metabolite imbalance can activate pattern recognition receptors (PRRs), forming a PRR microbiota reproductive axis that contributes to PCOS pathophysiology. This review synthesizes current insights into how gut-derived signals, including LPS, peptidoglycans, SCFAs, bile acids, and tryptophan metabolites, modulate TLR-, NLR-, and RLR-mediated pathways to disrupt ovarian, endometrial, and systemic immune regulation. We further propose a unifying framework, the Reproductive Immune Tolerance Disruption Theory, which posits that chronic PRR activation shifts reproductive tract immunity from a tolerogenic to a low-grade inflammatory state, thereby promoting hyperandrogenism, anovulation, insulin resistance, and metabolic dysfunction. We also summarize recent multi-omics and immunometabolic studies that clarify the crosstalk between gut microbial signatures and innate immune signaling. Finally, we highlight precision strategies, including PRR-selective immunomodulation, microbiota-based therapies, and epigenetic metabolic interventions that hold translational potential for redefining PCOS management. Understanding PRR-driven microbial immunomodulation provides a mechanistic framework for reconciling endocrine, metabolic, and reproductive abnormalities in PCOS, guiding the development of targeted therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Zhenjiang, Jiangsu 212300, PR China.
- School of Medicine, Nantong University, Zhenjiang, Jiangsu 212300, PR China.
- Biology Department, Faculty of Science, King Khalid University, P.O. Box 9004, Abha 61413, Saudi Arabia; Blood Products Quality Control and Research Department, National Organization for Research and Control of Biologic…
- Department of Laboratory Medicine, the Affiliated People's Hospital, Jiangsu University, Zhenjiang, Jiangsu 212002, PR China.
- Department of Dermatology and Venereology, the Affiliated People's Hospital, Jiangsu University, Zhenjiang, Jiangsu 212002, PR China. Electronic address: pfkdusuping@163.com.
Förderung
- Jiangsu Commission of Health
Zitieren
APA
Yuan, J., Sun, S., Ibrahim, E. H., Din, M. A. U., Mao, F., & Du, S. (2026). Gut microbiota and pattern recognition receptors in polycystic ovary syndrome. Journal of Reproductive Immunology, 175, 104882. https://doi.org/10.1016/j.jri.2026.104882
Vancouver
Yuan J, Sun S, Ibrahim EH, Din MAU, Mao F, Du S. Gut microbiota and pattern recognition receptors in polycystic ovary syndrome. Journal of Reproductive Immunology. 2026;175:104882. doi:10.1016/j.jri.2026.104882
BibTeX
@article{Yuan2026,
author = {Yuan, Jintao and Sun, Shiqiong and Ibrahim, Essam H and Din, Muhammad Azhar Ud and Mao, Fei and Du, Suping},
title = {Gut microbiota and pattern recognition receptors in polycystic ovary syndrome},
journal = {Journal of Reproductive Immunology},
year = {2026},
volume = {175},
pages = {104882},
doi = {10.1016/j.jri.2026.104882}
}
EUVIMED